Global Health

Primary tabs

Mon, 2009-03-09 11:54 — mdmcdonald

The mission of the Global Health Working Group is to explore and improve current and emerging states of health and human security worldwide.

General Topic Tags:

Adaptation

Problem, Solution, SitRep, or ?:

Solutions

Group:

Request group membership

Group description:

This Working Group is focused on exploring current and emerging states of health and human security worldwide.

Group roles and permissions:

Use default roles and permissions

Group visibility:

Public - accessible to all site users

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Aboubacar Conte	admin	Albert Gomez	Allan	Anthony	Carrielaj
Chisina Kapungu	ChrisAllen	Corey Watts	CPetry	DeannaPolk	Elhadj Drame
Gavin Macgregor...	Hadiatou Balde	hank_test	jranck	JSole	Kathy Gilbeaux
Lisa Stelly Thomas	loguest	Maeryn Obley	mdmcdonald	MDMcDonald_me_com	Mika Shimizu
mike kraft	njchapman	Norea	Tiaji Salaam-Blyther	tnovotny

Request group membership

Email address for group

Loss of Smell Occurs in 86 Percent of Mild COVID Cases, New Study Finds

Thu, 2021-01-07 18:45 — mike kraft

Loss of Smell Occurs in 86 Percent of Mild COVID Cases, New Study Finds According to researchers, 95 percent of patients who lost their sense of taste or smell recovered it within six months YahooNews

Most patients with mild symptoms of COVID-19 lose their sense of taste and smell but tend to recover it quickly, according to findings from a new study.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Loss of Smell Occurs in 86 Percent of Mild COVID Cases, New Study Finds
Log in or register to post comments

Blood Plasma Reduces Risk of Severe Covid-19 if Given Early

Thu, 2021-01-07 17:22 — mike kraft

A small but rigorous clinical trial in Argentina has found that blood plasma from recovered Covid-19 patients can keep older adults from getting seriously sick with the coronavirus — if they get the therapy within days of the onset of the illness.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Blood Plasma Reduces Risk of Severe Covid-19 if Given Early
Log in or register to post comments

Severe allergic reactions reported in the US after getting COVID-19 vaccine, but CDC says cases are rare

Thu, 2021-01-07 13:13 — mike kraft

Severe allergic reactions reported in the US after getting COVID-19 vaccine, but CDC says cases are rare The CDC detected 21 cases of anaphylaxis in a pool of more than 1.8 million administered first doses, translating to about 11 cases per million doses. Adrianna Rodriguez USA TODAY

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

EU agency authorizes Moderna's COVID-19 vaccine

Wed, 2021-01-06 10:28 — mike kraft

EU agency authorizes Moderna's COVID-19 vaccine AMSTERDAM (AP) — The European Union’s medicines agency gave the green light Wednesday to Moderna Inc.’s COVID-19 vaccine, a decision that gives the 27-nation bloc a second vaccine to use in the... AP NEWS

AMSTERDAM (AP) — The European Union’s medicines agency gave the green light Wednesday to Moderna Inc.’s COVID-19 vaccine, a decision that gives the 27-nation bloc a second vaccine to use in the desperate battle to tame the virus rampaging across the continent.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU agency authorizes Moderna's COVID-19 vaccine
Log in or register to post comments

Warning of Shortages, Researchers Look to Stretch Vaccine Supply

Wed, 2021-01-06 10:08 — mike kraft

WASHINGTON — Federal officials and drugmakers, faced with a slower-than-expected rollout of the coronavirus vaccine, are racing to find ways to expand the supply, looking at lowering the required dosage and extracting more doses from the supplies they have.

Just weeks into the vaccine program, scientists at the National Institutes of Health and the drugmaker Moderna are analyzing data to see if they can double the supply of the company’s coronavirus vaccine by cutting doses in half. The study, though long planned, is increasingly urgent in the face of looming shortages as the country tries to fight off a surging pandemic.

Country / Region Tags:

General Topic Tags: